Biotech Stocks Hitting 52-week lows on Feb. 25)
AcelRx Pharmaceuticals Inc
ACRX 2.33%
Acorda Therapeutics Inc
ACOR 8.27%
AngioDynamics, Inc.
ANGO 0.79%
Aptevo Therapeutics Inc
APVO 8.89%
Artelo Biosciences Inc
ARTL 2.73%
Autolus Therapeutics Ltd – ADR
AUTL 4.88%
Aytu Bioscience Inc
AYTU 3.74%
Black Diamond Therapeutics Inc
BDTX 6.61%
Blueprint Medicines Corp
BPMC 0.46%
Chembio Diagnostics Inc
CEMI 12.37%
Enanta Pharmaceuticals Inc
ENTA 2.13%
Evolus Inc
EOLS 0.7%
(reacted to its fourth-quarter results)
Galectin Therapeutics Inc.
GALT 2.75%
KITOV PHARMA LT/S ADR
KTOV 2.06%
Lantheus Holdings Inc
LNTH 0.58%
(announced financial results for the fourth quarter)
MediciNova, Inc.
MNOV 1.69%
Medigus Ltd. ADR
MDGS 7.04%
Meridian Bioscience, Inc.
VIVO 2.08%
Misonix Inc
MSON 3.75%
Moleculin Biotech Inc
MBRX 5.07%
Myriad Genetics, Inc.
MYGN 1.97%
Neurometrix Inc
NURO 1.26%
Neuronetics Inc
STIM 1.86%
OncoSec Medical Inc
ONCS 2.11%
Orthofix Medical Inc
OFIX 1.59%
(reacted to its fourth-quarter results)
Pacific Biosciences of California
PACB 3.41%
PDS Biotechnology Corp
PDSB 6.35%
Pfizer Inc.
PFE 1.85%
Precipio Inc
PRPO 10.87%
Predictive Oncology Inc
POAI 5.31%
Pulse Biosciences Inc
PLSE 3.95%
REDHILL BIOPHAR/S ADR
RDHL 1.98%
(acquired rights to opioid-induced constipation drug)
Sangamo Therapeutics Inc
SGMO 27.98%
Sesen Bio Inc
SESN 1.33%
Stealth BioTherapeutics Corp
MITO 0.54%
Tetraphase Pharmaceuticals Inc
TTPH 3.28%
Theratechnologies Inc
THTX 2.55%
(announced its fourth-quarter results)
Tonix Pharmaceuticals Holding Corp
TNXP 37.57%
Zogenix, Inc.
ZGNX 5.87%
